182 related articles for article (PubMed ID: 20484950)
1. Retinal and ocular toxicity in ocular application of drugs and chemicals--part I: animal models and toxicity assays.
Penha FM; Rodrigues EB; Maia M; Dib E; Fiod Costa E; Furlani BA; Nunes Moraes Filho M; Dreyfuss JL; Bottós J; Farah ME
Ophthalmic Res; 2010; 44(2):82-104. PubMed ID: 20484950
[TBL] [Abstract][Full Text] [Related]
2. Retinal and ocular toxicity in ocular application of drugs and chemicals--part II: retinal toxicity of current and new drugs.
Penha FM; Rodrigues EB; Maia M; Furlani BA; Regatieri C; Melo GB; Magalhães O; Manzano R; Farah ME
Ophthalmic Res; 2010; 44(4):205-24. PubMed ID: 20699625
[TBL] [Abstract][Full Text] [Related]
3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
4. Retinal electrophysiology for toxicology studies: applications and limits of ERG in animals and ex vivo recordings.
Rosolen SG; Kolomiets B; Varela O; Picaud S
Exp Toxicol Pathol; 2008 Jun; 60(1):17-32. PubMed ID: 18294830
[TBL] [Abstract][Full Text] [Related]
5. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
Box RJ; Spielmann H
Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
[TBL] [Abstract][Full Text] [Related]
6. Toxicity and retinal penetration of infliximab in primates.
Melo GB; Moraes Filho MN; Rodrigues EB; Regatieri CV; Dreyfuss JL; Penha FM; Pinheiro MM; Coimbra RC; Haapalainen EF; Farah ME
Retina; 2012 Mar; 32(3):606-12. PubMed ID: 22080907
[TBL] [Abstract][Full Text] [Related]
7. Improving toxicity screening and drug development by using genetically defined strains.
Festing MF
Methods Mol Biol; 2010; 602():1-21. PubMed ID: 20012389
[TBL] [Abstract][Full Text] [Related]
8. Standardized electroretinography in primates: a non-invasive preclinical tool for predicting ocular side effects in humans.
Bee WH
Curr Opin Drug Discov Devel; 2001 Jan; 4(1):81-91. PubMed ID: 11727327
[TBL] [Abstract][Full Text] [Related]
9. Current in vivo assays for cutaneous toxicity: local and systemic toxicity testing.
Auletta CS
Basic Clin Pharmacol Toxicol; 2004 Nov; 95(5):201-8. PubMed ID: 15546473
[TBL] [Abstract][Full Text] [Related]
10. Acute toxicity study of a simian immunodeficiency virus-based lentiviral vector for retinal gene transfer in nonhuman primates.
Ikeda Y; Yonemitsu Y; Miyazaki M; Kohno R; Murakami Y; Murata T; Goto Y; Tabata T; Ueda Y; Ono F; Suzuki T; Ageyama N; Terao K; Hasegawa M; Sueishi K; Ishibashi T
Hum Gene Ther; 2009 Sep; 20(9):943-54. PubMed ID: 19416079
[TBL] [Abstract][Full Text] [Related]
11. Retinal toxicity of commercially available intravitreal ketorolac in albino rabbits.
Komarowska I; Heilweil G; Rosenfeld PJ; Perlman I; Loewenstein A
Retina; 2009 Jan; 29(1):98-105. PubMed ID: 18626418
[TBL] [Abstract][Full Text] [Related]
12. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
13. Ocular toxicity of intravitreal tacrolimus.
Passos E; Genaidy MM; Peyman GA
Ophthalmic Surg Lasers; 2002; 33(2):140-4. PubMed ID: 11942546
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of birefringent retinal inclusions in cynomolgus monkeys after high doses of canthaxanthin.
Goralczyk R; Buser S; Bausch J; Bee W; Zühlke U; Barker FM
Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):741-52. PubMed ID: 9071228
[TBL] [Abstract][Full Text] [Related]
15. Safety assessment of drug metabolites: implications of regulatory guidance and potential application of genetically engineered mouse models that express human P450s.
Powley MW; Frederick CB; Sistare FD; DeGeorge JJ
Chem Res Toxicol; 2009 Feb; 22(2):257-62. PubMed ID: 19170595
[TBL] [Abstract][Full Text] [Related]
16. Preclinical efficacy and safety models for mAbs: the challenge of developing effective model systems.
Dixit R; Coats S
IDrugs; 2009 Feb; 12(2):103-8. PubMed ID: 19204884
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal moxifloxacin: retinal safety study with electroretinography and histopathology in animal models.
Gao H; Pennesi ME; Qiao X; Iyer MN; Wu SM; Holz ER; Mieler WF
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1606-11. PubMed ID: 16565399
[TBL] [Abstract][Full Text] [Related]
18. Mouse models of ocular diseases.
Chang B; Hawes NL; Hurd RE; Wang J; Howell D; Davisson MT; Roderick TH; Nusinowitz S; Heckenlively JR
Vis Neurosci; 2005; 22(5):587-93. PubMed ID: 16332269
[TBL] [Abstract][Full Text] [Related]
19. Retinal toxicity of intravitreal genistein in a rabbit model.
Fiore T; Iaccheri B; Pietrolucci F; Giansanti F; Cavaliere A; Coltella R; Mameli MG; Androudi S; Brazitikos P; Cagini C
Retina; 2010 Oct; 30(9):1536-41. PubMed ID: 20634778
[TBL] [Abstract][Full Text] [Related]
20. Ocular pigmentation protects the rabbit retina from gentamicin-induced toxicity.
Zemel E; Loewenstein A; Lei B; Lazar M; Perlman I
Invest Ophthalmol Vis Sci; 1995 Aug; 36(9):1875-84. PubMed ID: 7635661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
